Clinical trial
S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma…
NCT00104988 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00104988 |
|---|---|
| Title | S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery |
| Official title | A Phase II Trial of Combination Thalidomide Plus Temozolomide in Patients With Metastatic Malignant Melanoma |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Drug |
| Interventions | temozolomide, thalidomide |
| Enrollment | 64 |
| Start date | Jun 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Aug 1, 2009 |
| First posted | Mar 4, 2005 |
| Last update posted | Aug 22, 2012 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: